Method for examining WT1-related disease

Details Method for examining WT1-related disease Method for examining WT1-related disease

2005-01-19

2010-11-02

Rawlings, Stephen L (Department: 1643)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C436S064000, C436S500000, C530S350000, C530S387100, C530S387700, C530S387900, C530S389700

Reexamination Certificate

active

07824865

ABSTRACT:
The invention provides a method for testing a WT1-related disease, such as leukemia, a solid cancer, or an atypia, for diagnosing the disease, evaluating the course of cure and the prognosis of the disease more simply with high reliability, the method comprises measuring the amount of antibody against WT1 in a sample and using the measurement value and the time course of the value as a clinical marker for the testing.

REFERENCES:
patent: 5633142 (1997-05-01), Herlyn et al.
patent: 6225051 (2001-05-01), Sugiyama et al.
patent: 2003/0082194 (2003-05-01), Gaiger et al.
patent: 2003/0082196 (2003-05-01), Gaiger et al.
patent: 2003/0215458 (2003-11-01), Gaiger et al.
patent: WO 97/39354 (1997-10-01), None
patent: 00/18795 (2000-04-01), None
Menssen H.D. et.al. Detection by monoclonal antibodies of the Wilm's tumor (WT1) nuclear protein in patients with acute leukemia. Int.j.Cancer. 70: 518-523, 1997.
Gaiger A. et.al. Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood. 96: 1480-1489, 2000.
Siehl et al. (Ann. Hematol. 2004; 83: 745-750).
Zolg et al. (Mol. Cell. Prot. 2004; 3 (4): 345-354).
Call et al. (Cell. Feb. 9, 1990; 60: 509-520).
Gessler et al. (Nature. Feb. 22, 1990; 343 (6260): 774-778).
Inoue et al. (Blood. Apr. 15, 1998 ; 91 (8): 2969-2976).
Lacroix et al. (Sem. Surg. Oncol. 2001; 20: 252-264).
Tsavellas et al. (Br. J. Surg. Oct. 2001; 88 (10): 1307-1320).
Leifers et al. (Histopathology. May 1999; 34 (5): 385-390.
Calaluce et al. (J. Surg. Oncol. 1998; 67: 194-202).
Miyamura et al. (Int. J. Hematol. 2004; 79: 243-249).
Elisseeva, O.A., “Humoral immune responses against Wilms' tumor gene WT1 product in patients with hematopoietic matlignancies,”Osaka Daigaku Igaku Zassi, Osaka Univ. Society, Jan. 2001, vol. 52, pp. 63-72.
Inoue, K. et al., “WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia,”Blood, Nov. 1, 1994, vol. 84, pp. 3071-3079.
Tamaki, H. et al., “The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes,”Leukemia, 1999, vol. 13, pp. 393-399.
Volinelich, L. et al., “A monoclonal antibody (WT1) for detecting leukemias of T-cells precursors (T-ALL),”Blood, Nov. 1983, vol. 62, pp. 1108-1113.
Gaiger, A., et al., “WT-1 specific serum antibodies in patients with leukemia,”Clinical Cancer Research, Mar. 2001, vol. 7, pp. 761-765.
Gaiger, A., et al., “Immunity to WT1 in the animal model and in patients with acute myeloid leukemia,”Blood, Aug. 15, 2000, vol. 96, pp. 1480-1489.
Elisseva, O.A. et al., “Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies,”Blood, May 1, 2002, vol. 99, pp. 3272-3279.
Gaiger et al,Blood, 94 (10, Suppl. 1, part I):78a(1999).
Haruo Sugiyama, “Hakketsu byou no Idenshi Shindan: WT1 ni yoru Saihatsu, Kankai, Hasshou Yosoku” Rinshou Byouri (Feb. 2000), vol. 48, No. 2, pp. 155-161.
Olga A. Elisseeva, “Zouketsuki Akusei Shikkan Kanja ni okeru Wilms' tumor Idenshi (WT1) Sanbutsu no taisuru Ekisei Meneki Hannou”, Osada Daigaku Igaku Zasshi (Jan. 2001, vol. 52, No. 12, Separate vol. 2, pp. 63-72.
Gaiger et al, Clin Cancer REs. Mar. 2001; 7 (3 Suppl): 761s-765s.
Ladomery M, et al., J Cell Sci. 2003; 116; 1539-49.
Loeb, DM et al Leukemia May 2003; 17 (5): 965-71.
Dumur CI, et al, Anal Biochem, Oct. 1, 2002; 309 (1); 127-36.
Ward AM Developmental Oncol. 1985; 21; 90-106.
Tockman MS, et al., Cancer Res. 1992; 52 (Suppl.): 2711s-2718s.
Gaiger et al,Blood, Aug. 15, 2000, vol. 96, No. 4.
Surinder S. Sahota et al., “VHGene Analysis of Clonally Related IgM and IgG From Human Lymphoplasmacytoid B-Cell Tumors With Chronic Lymphocytic Leukemia Features and High Serum Monoclonal IgG”, Blood, 1998, 91(1): 238-243.
M. Wakai et al., “IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing”, Autoimmunity, 1994, 19(1): 39-48.
Franco Fais et al., “Examples of In Vivo Isotype Class Switching in IgM+ Chronic Lymphocytic Leukemia B Cells”, Journal of Clinical Investigation, 1996, 98(7):1659-1666.

Affiliated with

Also associated with

Rating

Method for examining WT1-related disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for examining WT1-related disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for examining WT1-related disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4198778